You searched for: cancer
31 to 40 of 168 results
Show
results per page
Matched phrases in profile:
Melanoma is the fourth most common cancer with >11,000 Australians diagnosed each year resulting… transcriptome, methylation) as well as Spatial Profiling to greater understand the early hallmarks of pre-skin cancer development.… Single nucleotide polymorphisms in obesity-related genes and the risk of esophageal cancers… Laser capture microdissection to empower cancer discoveries, improve diagnosis, treatment and outcomes in amyloidosis patients… development a Genomics Atlas of pre-skin cancer lesions. If you are interested to hear… Genomics Atlas of pre-skin cancer lesions… biomarkers for melanoma progression and the development a Genomics Atlas of pre-skin cancer… Epigenetic gene inactivation of tumour suppressor genes underlies several human cancers. The…
Dr Mitchell Stark is a molecular biologist and Group Leader/Senior Research Fellow from the Dermatology Research Centre (DRC) based at the Frazer Institute. His group has extensive experience in microRNA biology and biomarker discovery, next-generation sequencing, bioinformatics, and functional anal …
Matched phrases in profile:
Cancers in Australia in 2010 attributable to infectious agents… Obesity-induced Barrett's oesophagus and associated cancer: mechanisms and diagnostic tools… Obesity and cancer… Professor Bradley Kendall is a clinical academic Gastroenterologist and Cancer Epidemiologist… average risk for developing EAC; these individuals might benefit from targeted cancer-prevention strategies. …
Professor Bradley Kendall is a clinical academic Gastroenterologist and Cancer Epidemiologist. He is currently a Senior Staff Gastroenterologist (Eminent) at the Princess Alexandra Hospital, Brisbane with over 30 years of experience in clinical practice. His clinical training included Fellowships in …
Professor Kendall’s work on the role of obesity in gastrointestinal cancer has been acknowledged nationally and internationally. His work has a strong translational focus contributing to the development of clinical risk prediction tools, national clinical guidelines, and position statements. As an …
Matched phrases in profile:
modalities of neoadjuvant therapy – results from the AGITG DOCTOR trial and the cancer evolution biobank… Cancer genetics… Barbour. Dr Brosda was awarded a PhD in bioinformatics and cancer genetics from the… set of 89 esophageal cancer samples. The most hypermethylated tumors showed worse patient survival.…
Dr Sandra Brosda is a Research Fellow within the Surgical Oncology group led by Professor Andrew Barbour.
Dr Brosda was awarded a PhD in bioinformatics and cancer genetics from the University of Queensland in November 2020. Her research focused on biomarker discovery and intra-tumour heterogeneity …
Matched phrases in profile:
Investigating T cell immunity in cancer: achievements and prospects… 'New Era' for personalised health care for head and neck cancer treatment… immunotherapies/vaccines for virally associated cancers by regulating the function of cytotoxic T-cells. In… therefore become a target for cancer therapy. Cetuximab is a chimeric human/mouse monoclonal antibody (mAb…
I am an enthusiastic immunologist with strong background in molecular biology techniques, including transcriptional profiling and vaccine development (Cruz JL et al., J Virol, 2013; Cruz JL et al., PloS Pathogens, 2011). I have been developing my professional, research and project management skills, …
Publication Quality
To date, I have published 24 indexed journal articles, with 2 publications in the top 5% and 1 publication in the top 10% most cited publications worldwide (field-weighted) (SciVal, May 2022). I am the first (5/24) or co-first (3/24) author on 40% of my papers and senior (last) …
Matched phrases in profile:
with concurrent non-contrast CT scanning on the management of operable pancreatic and peri-ampullary cancers… Management of gastrointestinal cancers… Associate Professor Melissa Eastgate is the Operation Director of Cancer Care Services at the… operable pancreas cancer is unclear. We, therefore, wanted to investigate the impact of PET/CT on management, by incorporating it into routine work-up.…
Associate Professor Melissa Eastgate is the Operation Director of Cancer Care Services at the RBWH, acting stream lead Metro North HHS Cancer Care Services and has acted as the Executive Director of Cancer Care Services. Melissa is the current Chair of the Medical Oncology Group of Australia. Melis …
Matched phrases in profile:
Effect of radiotherapy dose and volume on relapse in Merkel cell cancer of the skin… radiation oncologist and a leading authority in head and neck and skin cancer. With over 20 years… cancer or its treatment. This chapter describes the RT effects associated with commonly treated…
Profile Summary
Dr Sandro Porceddu is an internationally recognised radiation oncologist and a leading authority in head and neck and skin cancer. With over 20 years experience in medicine his areas of clinical expertise include head and neck cancer, skin cancer, sarcoma and lymphoma. He is current …
Dr Porceddu’s has been investigating methods to reduce the morbidity of treatment, improve cure rates and quality of life for cancer patients. He runs an active head and neck/skin cancer research program and is the principal investigator of numerous trials including an NHMRC-supported Randomised P …
Matched phrases in profile:
Cell biology: Ran, mitosis and the cancer Lconnection… Cancer chemotherapy… studying cancer, autoimmune diseases, infection and immunity, and the genetic basis of disease… -9 phosphorylation in the regulation of apoptosis during development and in pathological states, including cancer.…
Paul Clarke is Director of the Frazer Institute, a leading translational medical research centre studying cancer, autoimmune diseases, infection and immunity, and the genetic basis of disease. Professor Clarke became Director in 2017 and was previously Associate Dean (Research) in Medicine at the Un …
Matched phrases in profile:
COPD: the risk of cancer and the impact on cancer care… , undertaking a PhD in the field of lung cancer diagnosis. He has a keen clinical and research interest in… bronchoscopic ablative therapies for lung cancer, focusing on focal parenchymal lesions. Background: This…
Dr Gerry Olive is a Queensland trained Respiratory Physician and early career researcher, undertaking a PhD in the field of lung cancer diagnosis. He has a keen clinical and research interest in the diagnostic approach to nodules and diagnostic bronchoscopy, including endobronchial ultrasound.
Matched phrases in profile:
Phenotypic and molecular dissection of Metaplastic Breast Cancer and the prognostic implications… Radiosensitising metastatic breast cancers by targeting DNA repair… The molecular basis of breast cancer in young women… Dr Malcolm Lim is a molecular biologist who specialises in breast cancer brain metastasis… global breast cancer mortality. This group is extremely heterogeneous and by definition exhibits…
Dr Malcolm Lim is a molecular biologist who specialises in breast cancer brain metastasis. Currently, he works in the Molecular Breast Pathology Lab with Profs Sunil Lakhani and Peter Simpson at The University of Queensland Centre for Clinical Research.
Dr Lim's research interests lies in understan …
Matched phrases in profile:
extracellular vesicles by the placenta during gestation, and tumour cells in ovarian cancer… Hypoxia increases the exosome release from ovarian cancer cells and promotes the epithelial-mesenchymal transition of target cells… Extracellular vesicles and ovarian cancer… UniQuest-INOVIQ Umbrella Research and Option Agreement: Exosome based ovarian cancer screening… realistic that a clinically useful antenatal screening test can be developed. Unlike diseases such as cancer… Assays for clinically relevant complications (including ovarian cancers, and obstetrical syndromes… Pancreatic cancer is the fourth most common cause of death due to cancer in the world. It is known…
I am Professor, NHMRC Investigator Fellow (EL2) and group leader (Exosome Biology Laboratory) at UQ Centre for Clinical Research. I am nationally and internationally (>20 invitations to international meetings in the last 5 years) acknowledged key opinion leader on Extracellular Vesicle (rated 3th w …
My research program focused on obstetrics and gynaecology, and it has investigated the release of extracellular vesicles by the placenta during gestation, and tumour cells in ovarian cancer progression, and their utility as a biomarker for a wide range of pregnancy complications, and ovarian cancer. …